An Activist Hedge Fund Manager Thinks This $100 Billion Biotech Company Could Be Worth 80% More (AMGN)
Dan Loeb thinks Amgen could be worth $249 per share, or 80% more than current levels. In his latest filing with the SEC, Loeb's Third Point was shown to be holding 450,000 shares of the company...
Login to comment.